KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Charles River Laboratories International (CRL) Leases (2019 - 2025)

Charles River Laboratories International has reported Leases over the past 7 years, most recently at $24.7 million for Q4 2025.

  • Quarterly results put Leases at $24.7 million for Q4 2025, down 94.02% from a year ago — trailing twelve months through Dec 2025 was $24.7 million (down 94.02% YoY), and the annual figure for FY2025 was $24.7 million, down 94.02%.
  • Leases for Q4 2025 was $24.7 million at Charles River Laboratories International, down from $374.3 million in the prior quarter.
  • Over the last five years, Leases for CRL hit a ceiling of $412.5 million in Q4 2024 and a floor of $24.7 million in Q4 2025.
  • Median Leases over the past 5 years was $378.7 million (2022), compared with a mean of $298.1 million.
  • Biggest five-year swings in Leases: surged 1301.98% in 2024 and later plummeted 94.02% in 2025.
  • Charles River Laboratories International's Leases stood at $29.4 million in 2021, then soared by 1230.85% to $391.8 million in 2022, then plummeted by 92.49% to $29.4 million in 2023, then surged by 1301.98% to $412.5 million in 2024, then plummeted by 94.02% to $24.7 million in 2025.
  • The last three reported values for Leases were $24.7 million (Q4 2025), $374.3 million (Q3 2025), and $385.8 million (Q2 2025) per Business Quant data.